(Q45878208)

17 December 2017

title

Noninvasive dual modality in vivo monitoring of the persistence and potency of a tumor targeted conditionally replicating adenovirus (English)

1 reference

17 December 2017

1 reference

2

1 reference

17 December 2017

David T. Curiel

13

object named as

Curiel DT

1 reference

17 December 2017

Kanerva A

1

1 reference

17 December 2017

Peng KW

3

1 reference

17 December 2017

Ranki T

4

1 reference

17 December 2017

Kangasniemi L

5

1 reference

17 December 2017

Chaudhuri TR

6

1 reference

17 December 2017

Desmond RA

7

1 reference

17 December 2017

Wang M

8

1 reference

17 December 2017

Takayama K

9

1 reference

17 December 2017

Hakkarainen T

10

1 reference

17 December 2017

Alfthan H

11

1 reference

17 December 2017

Stenman UH

12

1 reference

17 December 2017

Hemminki A

14

1 reference

17 December 2017

publication date

1 January 2005

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

12

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

87-94

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302387

exact match

0 references

cites work

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302387

Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302387

Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302387

There are two different species B adenovirus receptors: sBAR, common to species B1 and B2 adenoviruses, and sB2AR, exclusively used by species B2 adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302387

Adenovirus type 11 uses CD46 as a cellular receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302387

CD46 is a cellular receptor for group B adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302387

Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302387

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302387

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302387

Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302387

Adenovirus immunoregulatory genes and their cellular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302387

Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302387

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302387

Carcinoembryonic antigen as a target for therapeutic anticancer vaccines: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302387

Episomal persistence of recombinant adenoviral vector genomes during the cell cycle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302387

Assays for noninvasive imaging of reporter gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302387

Gene therapy progress and prospects: noninvasive imaging of gene therapy in living subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302387

Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302387

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302387

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017